Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
INR 1124.7
(-0.77%)
INR 1124.7
(-0.77%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 437.2 Million INR | -51.57% |
| 2022 | 742.22 Million INR | 11.93% |
| 2021 | 663.1 Million INR | 9.39% |
| 2020 | 606.16 Million INR | -10.67% |
| 2019 | 678.6 Million INR | 9.52% |
| 2018 | 619.61 Million INR | 7.36% |
| 2017 | 577.11 Million INR | 6.18% |
| 2016 | 543.5 Million INR | 9.6% |
| 2015 | 495.91 Million INR | 10.34% |
| 2014 | 449.44 Million INR | 14.48% |
| 2013 | 392.61 Million INR | 8.96% |
| 2012 | 360.32 Million INR | 19.54% |
| 2011 | 301.41 Million INR | 15.88% |
| 2010 | 260.1 Million INR | 13.22% |
| 2009 | 229.73 Million INR | 14.08% |
| 2008 | 201.37 Million INR | 6.73% |
| 2007 | 188.68 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 62.88 Million INR | -39.55% |
| 2023 Q3 | 216.39 Million INR | 5.2% |
| 2023 FY | 359.47 Million INR | -51.57% |
| 2023 Q1 | 171.66 Million INR | -3.38% |
| 2023 Q2 | 205.71 Million INR | 19.83% |
| 2023 Q4 | 104.02 Million INR | -51.93% |
| 2022 Q4 | 177.67 Million INR | -11.45% |
| 2022 Q1 | 172.5 Million INR | 8.12% |
| 2022 Q3 | 200.64 Million INR | 4.83% |
| 2022 FY | 742.22 Million INR | 11.93% |
| 2022 Q2 | 191.4 Million INR | 10.95% |
| 2021 FY | 663.1 Million INR | 9.39% |
| 2021 Q1 | 151.74 Million INR | -11.77% |
| 2021 Q2 | 167.24 Million INR | 10.21% |
| 2021 Q3 | 184.56 Million INR | 10.35% |
| 2021 Q4 | 159.55 Million INR | -13.55% |
| 2020 FY | 606.16 Million INR | -10.67% |
| 2020 Q1 | 130.46 Million INR | -21.61% |
| 2020 Q2 | 146.5 Million INR | 12.3% |
| 2020 Q3 | 161.45 Million INR | 10.2% |
| 2020 Q4 | 171.99 Million INR | 6.53% |
| 2019 Q1 | 152.61 Million INR | -5.85% |
| 2019 Q4 | 166.44 Million INR | -9.05% |
| 2019 Q2 | 176.54 Million INR | 15.68% |
| 2019 Q3 | 183 Million INR | 3.66% |
| 2019 FY | 678.6 Million INR | 9.52% |
| 2018 Q2 | 153.19 Million INR | 10.41% |
| 2018 FY | 619.61 Million INR | 7.36% |
| 2018 Q4 | 162.1 Million INR | -2.09% |
| 2018 Q1 | 138.74 Million INR | 32.74% |
| 2018 Q3 | 165.56 Million INR | 8.08% |
| 2017 Q3 | 148.68 Million INR | 0.15% |
| 2017 Q4 | 104.52 Million INR | -29.7% |
| 2017 Q2 | 148.46 Million INR | 1.73% |
| 2017 Q1 | 145.94 Million INR | -1.52% |
| 2017 FY | 577.11 Million INR | 6.18% |
| 2016 Q1 | 127.71 Million INR | -6.24% |
| 2016 Q4 | 148.19 Million INR | 7.31% |
| 2016 Q3 | 138.1 Million INR | 8.09% |
| 2016 Q2 | 127.77 Million INR | 0.04% |
| 2016 FY | 543.5 Million INR | 9.6% |
| 2015 Q4 | 136.22 Million INR | 12.32% |
| 2015 FY | 495.91 Million INR | 10.34% |
| 2015 Q1 | 118.12 Million INR | 6.9% |
| 2015 Q2 | 120.29 Million INR | 1.84% |
| 2015 Q3 | 121.27 Million INR | 0.81% |
| 2014 Q1 | 112.81 Million INR | 20.48% |
| 2014 FY | 449.44 Million INR | 14.48% |
| 2014 Q3 | 112.3 Million INR | 1.7% |
| 2014 Q4 | 110.49 Million INR | -1.61% |
| 2014 Q2 | 110.43 Million INR | -2.11% |
| 2013 Q4 | 93.63 Million INR | -9.1% |
| 2013 FY | 392.61 Million INR | 8.96% |
| 2013 Q3 | 103 Million INR | 7.78% |
| 2013 Q2 | 95.56 Million INR | -1.39% |
| 2013 Q1 | 96.91 Million INR | 18.41% |
| 2012 Q2 | 97.42 Million INR | 14.51% |
| 2012 Q1 | 85.07 Million INR | -1.71% |
| 2012 FY | 360.32 Million INR | 19.54% |
| 2012 Q4 | 81.84 Million INR | -14.73% |
| 2012 Q3 | 95.98 Million INR | -1.48% |
| 2011 Q3 | 75.94 Million INR | 0.0% |
| 2011 Q4 | 86.55 Million INR | 13.97% |
| 2011 FY | 301.41 Million INR | 15.88% |
| 2010 FY | 260.1 Million INR | 13.22% |
| 2009 FY | 229.73 Million INR | 14.08% |
| 2008 FY | 201.37 Million INR | 6.73% |
| 2007 FY | 188.68 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ANG Lifesciences India Limited | 219.92 Million INR | -98.795% |
| Add-Shop E-Retail Limited | 146.52 Million INR | -198.381% |
| Bacil Pharma Limited | 1.87 Million INR | -23225.242% |
| BDH Industries Limited | 57.03 Million INR | -666.598% |
| Beryl Drugs Limited | 93.77 Million INR | -366.249% |
| Cian Healthcare Limited | 59.19 Million INR | -638.536% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -22355.367% |
| Concord Drugs Limited | 91.83 Million INR | -376.093% |
| Deccan Health Care Limited | 36.24 Million INR | -1106.352% |
| DECIPHER LABS LIMITED | 277.6 Million INR | -57.495% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | -230.169% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | -178.747% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -16661.193% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -2555.044% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | -75.633% |
| Panchsheel Organics Limited | 68.15 Million INR | -541.45% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | -192.404% |
| Parnax Lab Limited | 80.59 Million INR | -442.493% |
| Makers Laboratories Limited | 83.1 Million INR | -426.095% |
| Medi-Caps Limited | 93.11 Million INR | -369.518% |
| MedPlus Health Services Limited | 2.42 Billion INR | 81.964% |
| Phaarmasia Limited | 50.52 Million INR | -765.309% |
| Parmax Pharma Limited | 99.31 Million INR | -340.212% |
| Patidar Buildcon Limited | 1.81 Million INR | -24041.69% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | -109.312% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -28588.058% |
| Trident Lifeline Limited | 46.87 Million INR | -832.786% |
| Tyche Industries Limited | 182.04 Million INR | -140.168% |
| Vivanza Biosciences Limited | 4.55 Million INR | -9498.375% |
| PRAVEG LIMITED | 77.18 Million INR | -466.461% |
| Smruthi Organics Limited | 261.73 Million INR | -67.042% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -1272.402% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | -199.27% |
| Sastasundar Ventures Limited | 846.78 Million INR | 48.369% |
| Transchem Limited | 8.47 Million INR | -5059.991% |
| Trinity League India Limited | -1.08 Million INR | 40358.379% |
| Vikram Thermo (India) Limited | 104.27 Million INR | -319.278% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -2068.035% |
| Sunil Healthcare Limited | 438.1 Million INR | 0.206% |
| Syschem (India) Limited | 64.13 Million INR | -581.728% |
| Zenith Healthcare Limited | 45.97 Million INR | -850.903% |
| Zenlabs Ethica Limited | 57.89 Million INR | -655.171% |
| Mercury Laboratories Limited | 217.24 Million INR | -101.253% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -3454.376% |
| Vasundhara Rasayans Limited | 145.5 Million INR | -200.471% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | -137.506% |
| Roopa Industries Limited | 24.63 Million INR | -1674.735% |
| PANJON LTD. | 33.77 Million INR | -1194.313% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | -471.556% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -408503.738% |
| Anuh Pharma Limited | 263.04 Million INR | -66.21% |
| Crestchem Limited | 50.8 Million INR | -760.599% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -10015.826% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | -105.356% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | -21.292% |
| Trimurthi Limited | 4.81 Million INR | -8987.633% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | -426.418% |
| Norris Medicines Limited | 18.2 Million INR | -2301.551% |
| Veerhealth Care Limited | 15.38 Million INR | -2742.322% |
| Lactose (India) Limited | 111.66 Million INR | -291.544% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -1738.545% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | -55.683% |
| Gennex Laboratories Limited | 130.37 Million INR | -235.34% |
| Denis Chem Lab Limited | 453.36 Million INR | 3.565% |
| Colinz Laboratories Limited | 31.19 Million INR | -1301.391% |
| Godavari Drugs Limited | 359.01 Million INR | -21.781% |
| Zenotech Laboratories Limited | 94.82 Million INR | -361.081% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | -319.845% |
| Bharat Parenterals Limited | 255.97 Million INR | -70.798% |
| Coral Laboratories Limited | 189.75 Million INR | -130.401% |
| Evoq Remedies Limited | 4.51 Million INR | -9579.123% |
| Kerala Ayurveda Limited | 399.64 Million INR | -9.399% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -17529.274% |
| Natural Capsules Limited | 444.7 Million INR | 1.685% |
| Auro Laboratories Limited | 157.37 Million INR | -177.81% |